Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain

[1]  L. Watkins,et al.  Stereochemistry and innate immune recognition: (+)‐norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll‐like receptor 4 signaling , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Yibo Wang,et al.  Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists , 2018, J. Chem. Inf. Model..

[3]  L. Watkins,et al.  Toll‐like receptors and their role in persistent pain , 2017, Pharmacology & therapeutics.

[4]  R. Isseroff,et al.  Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state , 2016, Brain, Behavior, and Immunity.

[5]  Wang Xiaohui,et al.  Toll-like Receptor 4 Small Molecule Modulators , 2016 .

[6]  Y. Zhang,et al.  Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4 , 2015, British journal of pharmacology.

[7]  T. Yaksh,et al.  Differences in cisplatin‐induced mechanical allodynia in male and female mice , 2015, European journal of pain.

[8]  S. Maier,et al.  Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4. , 2015, CNS & neurological disorders drug targets.

[9]  L. Watkins,et al.  Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists. , 2015, Journal of medicinal chemistry.

[10]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[11]  S. Maier,et al.  DAT isn’t all that: cocaine reward and reinforcement requires Toll Like Receptor 4 signaling , 2014, Molecular Psychiatry.

[12]  S. Maier,et al.  Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae , 2014, Neuroscience.

[13]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[14]  U. Andersson,et al.  Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis , 2014, PAIN®.

[15]  L. Watkins,et al.  In vivo veritas: (+)-Naltrexone's actions define translational importance: A letter in response to Skolnick et al. 'Translational potential of naloxone and naltrexone as TLR4 antagonists'. , 2014, Trends in pharmacological sciences.

[16]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[17]  T. Yaksh,et al.  Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice , 2013, Journal of Neuroinflammation.

[18]  P. Nordlund,et al.  Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay , 2013, Science.

[19]  L. Watkins,et al.  Rifampin inhibits Toll‐like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Xiaohui Wang,et al.  Targeting Toll-like receptors with small molecule agents. , 2013, Chemical Society reviews.

[21]  R. Stote,et al.  Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development. , 2013, Journal of medicinal chemistry.

[22]  A. Aguzzi,et al.  Microglia: Scapegoat, Saboteur, or Something Else? , 2013, Science.

[23]  Y. Ikeda,et al.  Reduced Surface Expression of TLR4 by a V254I Point Mutation Accounts for the Low Lipopolysaccharide Responder Phenotype of BALB/c B Cells , 2013, The Journal of Immunology.

[24]  S. Maier,et al.  Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement , 2012, The Journal of Neuroscience.

[25]  Koichi Fukase,et al.  Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 , 2012, Proceedings of the National Academy of Sciences.

[26]  Jacob Thomas,et al.  Morphine activates neuroinflammation in a manner parallel to endotoxin , 2012, Proceedings of the National Academy of Sciences.

[27]  J. Mogil,et al.  Spinal Cord Toll-Like Receptor 4 Mediates Inflammatory and Neuropathic Hypersensitivity in Male But Not Female Mice , 2011, The Journal of Neuroscience.

[28]  J. Lindh,et al.  What is a relevant statin concentration in cell experiments claiming pleiotropic effects? , 2011, British journal of clinical pharmacology.

[29]  Jon Cohen,et al.  A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis* , 2010, Critical care medicine.

[30]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[31]  M. Shahbazi,et al.  A simple and sensitive HPLC-UV method for quantitation of lovastatin in human plasma: application to a bioequivalence study. , 2009, Biological & pharmaceutical bulletin.

[32]  E. Chan,et al.  Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2*♦ , 2009, The Journal of Biological Chemistry.

[33]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[34]  P. Pristovsek,et al.  Taxanes inhibit human TLR4 signaling by binding to MD‐2 , 2008, FEBS letters.

[35]  James P. Snyder,et al.  Paclitaxel Binding to Human and Murine MD-2* , 2008, Journal of Biological Chemistry.

[36]  S. Maier,et al.  Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4) , 2008, The European journal of neuroscience.

[37]  P. Pristovsek,et al.  MD‐2 as the target of curcumin in the inhibition of response to LPS , 2007, Journal of leukocyte biology.

[38]  Tania Nolan,et al.  Quantification of mRNA using real-time RT-PCR , 2006, Nature Protocols.

[39]  P. Ridker,et al.  Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms , 2005, Nature Reviews Drug Discovery.

[40]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P Couvreur,et al.  Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties , 2005, Journal of neurochemistry.

[42]  S. Maier,et al.  Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats , 2004, The European journal of neuroscience.

[43]  P. Tobias,et al.  MD-2 binds to bacterial lipopolysaccharide. , 2001, Journal of endotoxin research.

[44]  S. Maier,et al.  Intrathecal HIV-1 Envelope Glycoprotein gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines , 2001, The Journal of Neuroscience.

[45]  K. Miyake,et al.  MD-2 Enables Toll-Like Receptor 2 (TLR2)-Mediated Responses to Lipopolysaccharide and Enhances TLR2-Mediated Responses to Gram-Positive and Gram-Negative Bacteria and Their Cell Wall Components1 , 2001, The Journal of Immunology.

[46]  R. Kriwacki,et al.  Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. , 1999, Journal of molecular biology.

[47]  S. Maier,et al.  A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats , 1999, Journal of Neuroscience Methods.

[48]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[49]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[50]  Marcel Leist,et al.  The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. , 2009, ALTEX.

[51]  H. Strasburger,et al.  Fitting the psychometric function , 1999, Perception & psychophysics.

[52]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .